|
|
|
|
|
|
|
|
|
|
€ million |
Remaining |
Merck Serono |
Consumer Health |
Performance Materials |
Merck Millipore |
Total |
Total |
|
Patents, licenses and similar rights, brands, trademarks and other |
|
|
|
|
|
|
|
|
Finite useful life |
|
3,813.0 |
13.3 |
2,093.4 |
38.1 |
5,957.8 |
6,812.1 |
|
Rebif ® |
7.0 |
2,577.0 |
– |
– |
– |
2,577.0 |
2,944.9 |
|
Gonal-f ® |
6.0 |
569.7 |
– |
– |
– |
569.7 |
664.6 |
|
Saizen ® |
7.0 |
215.1 |
– |
– |
– |
215.1 |
245.9 |
|
Humira ® |
5.0 |
184.8 |
– |
– |
– |
184.8 |
223.7 |
|
Avonex ® |
0.5 |
23.8 |
– |
– |
– |
23.8 |
72.2 |
|
Enbrel ® |
– |
– |
– |
– |
– |
– |
38.0 |
|
Puregon ® |
2.0 |
22.9 |
– |
– |
– |
22.9 |
34.4 |
|
Other technologies |
1.4–15.0 |
218.5 |
0.2 |
487.5 |
36.0 |
742.2 |
789.2 |
|
Brands |
1.6–11.5 |
– |
13.1 |
281.3 |
0.6 |
295.0 |
333.4 |
|
Customer relationships |
1.0–14.5 |
1.2 |
– |
1,324.6 |
1.5 |
1,327.3 |
1,465.8 |
|
|
|
|
|
|
|
|
|
|
Indefinite useful life |
– |
150.3 |
– |
– |
6.3 |
156.6 |
87.9 |
|
|
|
|
|
|
|
|
|
|
Goodwill |
– |
1,681.2 |
164.6 |
2,826.1 |
23.8 |
4,695.7 |
4,716.4 |